The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages

The Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has demonstrated promising efficacy in a variety of hematologic malignancies. However, the precise mechanism of action of the drug remains to be fully elucidated. Tumor-infiltrating macrophages presented in the tumor microenvironment have b...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncotarget
Prif Awduron: Ping, Lingyan, Ding, Ning, Shi, Yunfei, Feng, Lixia, Li, Jiao, Liu, Yalu, Lin, Yufu, Shi, Cunzhen, Wang, Xing, Pan, Zhengying, Song, Yuqin, Zhu, Jun
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Impact Journals LLC 2017
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5503608/
https://ncbi.nlm.nih.gov/pubmed/28424405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16836
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg